Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
seemingly-harmless's Profile
Displaying 1-50 of 285 result(s).
CYDY CytoDyn Inc
05/19/2025 10:18:07 PM
where was europe during covid? cric (4)
CYDY CytoDyn Inc
05/16/2025 1:35:38 PM
so the FDA is narrow minded. seems (6)
CYDY CytoDyn Inc
05/16/2025 11:48:05 AM
ive got three fingers that havent b (5)
CYDY CytoDyn Inc
05/16/2025 11:17:59 AM
if ALL the PD-L1 Check Point Inhibi (4)
CYDY CytoDyn Inc
05/08/2025 12:03:08 PM
anecdotal did come off ECMO and it (13)
CYDY CytoDyn Inc
04/15/2025 10:53:48 PM
leqembi gets limited EU approval fo (5)
CYDY CytoDyn Inc
04/08/2025 1:45:35 PM
as long as the very same companies (4)
CYDY CytoDyn Inc
04/01/2025 12:00:48 PM
those pesky "glitches"...how many m (2)
CYDY CytoDyn Inc
03/30/2025 2:44:33 PM
but thats where you get it wrong...
CYDY CytoDyn Inc
03/30/2025 2:00:51 PM
how can there be different grades a
CYDY CytoDyn Inc
03/23/2025 4:54:02 PM
and zero repercussion in the aduhel (6)
CYDY CytoDyn Inc
03/07/2025 12:51:08 PM
duck duck go fixed the ad problem y (7)
CYDY CytoDyn Inc
03/04/2025 10:20:22 PM
DOGE and FDA facilities closures di (5)
CYDY CytoDyn Inc
03/03/2025 7:01:10 PM
more than half of the 26 women from (14)
CYDY CytoDyn Inc
02/28/2025 5:27:42 PM
yes i want the answer to this too.. (8)
CYDY CytoDyn Inc
02/26/2025 9:41:51 PM
safe to say the unmet need portion (1)
CYDY CytoDyn Inc
02/22/2025 11:32:15 AM
theory on alz cause https://www.sci (2)
CYDY CytoDyn Inc
02/16/2025 11:35:21 AM
these ads are unbearable. does it r (9)
CYDY CytoDyn Inc
02/10/2025 4:11:23 PM
teens dying flu https://www.sfgate. (2)
CYDY CytoDyn Inc
02/05/2025 12:21:26 PM
GBM mouse study results were surpri (2)
CYDY CytoDyn Inc
01/31/2025 9:00:04 PM
"glitches"...so we cant trust data. (2)
CYDY CytoDyn Inc
01/29/2025 6:43:42 PM
are you saying that is a confirmed
CYDY CytoDyn Inc
01/28/2025 3:59:23 PM
isnt that insider trading? or do we (1)
CYDY CytoDyn Inc
01/27/2025 3:31:18 PM
MASH competition - AKRO - liver fib (2)
CYDY CytoDyn Inc
01/22/2025 5:35:46 PM
that would be a significant and pat (5)
CYDY CytoDyn Inc
01/15/2025 12:17:37 PM
crazy that caplyta could bring in t (6)
CYDY CytoDyn Inc
12/30/2024 1:33:01 PM
very interesting movie about Laetri (4)
CYDY CytoDyn Inc
12/16/2024 11:09:19 AM
thats my problem with the real worl (8)
CYDY CytoDyn Inc
12/13/2024 4:00:47 PM
but is right to try available right
CYDY CytoDyn Inc
11/28/2024 10:35:58 PM
the FDA isnt supposed to "buy into" (13)
CYDY CytoDyn Inc
11/05/2024 11:17:31 AM
so how do drugs that we see adverti (7)
CYDY CytoDyn Inc
10/31/2024 1:34:04 PM
leronlimab and PFN1? https://www.sc (1)
CYDY CytoDyn Inc
10/24/2024 9:05:55 PM
wrenches in the pot - in that there (12)
CYDY CytoDyn Inc
10/23/2024 5:15:29 PM
was in large with IMMU because i re (18)
CYDY CytoDyn Inc
10/17/2024 1:56:50 PM
remind me again how OTC stocks are
CYDY CytoDyn Inc
10/07/2024 12:05:30 PM
bevacizumab approval process - was (6)
CYDY CytoDyn Inc
10/03/2024 10:48:20 AM
new york times article on MASH toda (1)
CYDY CytoDyn Inc
09/25/2024 11:07:40 AM
"X" doesnt let you copy and paste? (2)
CYDY CytoDyn Inc
09/19/2024 9:44:21 PM
i would think if they (who?) found (1)
CYDY CytoDyn Inc
09/19/2024 11:36:18 AM
so when leronlimab is shown to be e (6)
CYDY CytoDyn Inc
09/18/2024 12:45:51 PM
Merck said the 5 year OS rate was (6)
CYDY CytoDyn Inc
09/10/2024 11:41:20 AM
same old story...otherwise mindbogg (3)
CYDY CytoDyn Inc
09/02/2024 7:47:20 PM
docs pushing statins on me too...ne (5)
CYDY CytoDyn Inc
08/12/2024 7:53:02 PM
a delicate situation that shorts, b (4)
CYDY CytoDyn Inc
07/18/2024 3:45:31 PM
university of cambridge and Tregs - (1)
CYDY CytoDyn Inc
07/18/2024 12:32:45 PM
...and baby CAN dance (3)
CYDY CytoDyn Inc
07/10/2024 9:48:58 PM
quercetin...i thought that is good (1)
CYDY CytoDyn Inc
07/10/2024 1:16:09 PM
red gives me migraines also...maybe (1)
CYDY CytoDyn Inc
07/09/2024 10:13:12 AM
so crime pays...very handsomely (1)
CYDY CytoDyn Inc
06/28/2024 7:41:03 PM
yes a separate arm for LL only is c (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Ackermans & van Haaren Starts 2025 Strong with Positive Outlook
  • DNO ASA Announces Ex-Dividend Trading Details for Investors
  • Exciting Developments in IBA's Business Operations Q1 2025
  • Leidos Partners with Saudi Arabia for Enhanced Security Tech
  • GTN Partners with Galt & Taggart to Redefine Investments
  • Temenos Revolutionizes AI Banking Solutions with Microsoft Azure
  • Significant Shift in Banking: Embracing Technology for Growth
  • OKX Introduces xBTC on Aptos: Revolutionizing Bitcoin DeFi Use
  • HyperStrong's Innovative HyperBlock M: Revolutionizing Energy Storage
  • LG CNS Unveils Innovative PerfecTwin ERP at SAP Sapphire 2025
  • Cognizant Empowers Enterprises with Revolutionary AI Solutions
  • Innovative SiXG301 and SiXG302 SoCs Transforming IoT Potential
  • DMG Blockchain Solutions Achieves Notable Growth in Q2 2025
  • Innovative Scrap Tire Solutions: Niutech's Pyrolysis Journey
  • Frontera Energy's Strategic CAD$91 Million Share Purchase Plan
  • Velan Inc. Announces Impressive Year-End Financial Results
  • Health Alert: PennRose Farms Issues Cucumber Recall Announcement
  • Transforming Laboratory Efficiency: MGI Tech's Innovations
  • Kelun-Biotech's Innovative Treatment for Advanced Breast Cancer
  • UAD's Innovative Approach to Architecture at Venice Biennale
  • JIECANG Group Unveils Innovative Solutions at Interzum 2025
  • AnnJi Pharmaceutical Unveils Promising AJ201 Results in SBMA Trial
  • Strengthening Ties: China and Latin America Move Forward
  • AnnJi Pharmaceutical's Innovative AJ201 Shows Promise in SBMA
  • KSDMiner Leads in Cryptocurrency Mining with Enhanced Services
  • RD Technologies' Landmark Milestone with Stablecoins Ordinance
  • Archdiocese Settlement Offers Hope for Abuse Survivors' Justice
  • Elbit Systems Secures $512 Million from Share Offering
  • Legal Inquiry into Shareholder Rights on Recent Company Deals
  • Celltrion Expands YUFLYMA® Availability with New Interchangeability Status
  • Inmarsat Enhances Digital Strategy for Mitsui O.S.K. Lines
  • TSA Readies for Increased Traveler Volume This Holiday Season
  • Understanding the Urgent Need for Anesthesia Provider Solutions
  • DDB Capital's Strategic Expansion in Real Estate Development
  • Strategic Merger: Vigil Neuroscience and Sanofi Join Forces
  • Greenhawk Resources Moves Forward with Greenland Properties Venture
  • SK hynix Unveils Advanced UFS 4.1 Memory Solution for AI
  • Sanofi Expands Neurology Pipeline with Vigil Neuroscience Merger
  • Raymond James Financial Announces Latest Dividend Payments
  • Shocking Abuse Statistics from the Archdiocese Exposed
  • Oyster Enterprises II Acquisition Corp's IPO Raises $220 Million
  • Capitalize on Bitcoin's Rise: Daily Earnings with PAIRMiner
  • Trading 212 Reaches A$50 Billion in Client Assets Milestone
  • Outstanding Growth and Financial Performance by LexinFintech
  • NOVONIX Celebrates Key Tariff Decision Impacting Graphite Industry
  • Investors of Bakkt Holdings, Inc. Urged to Take Action Now
  • Cracker Barrel Welcomes Steve Bramlage to Its Board of Directors
  • BlackRock’s May Distributions for iShares ETFs Unveiled
  • Frankenmuth Insurance Welcomes New Chief Legal Officer
  • Zenas BioPharma Investors: An Update on Class Action Lawsuit
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site